Tellgen Corp (300642) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Based on the latest financial reports, Tellgen Corp (300642) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.19 Million ≈ $5.30 Million USD) by net assets (CN¥1.53 Billion ≈ $223.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tellgen Corp stock valuation for the company's overall valuation and market capitalisation.

Tellgen Corp - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tellgen Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tellgen Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tellgen Corp ranked by their cash flow conversion efficiency. Explore 300642 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shanghai Laimu Electronics Co Ltd SHG:603633	-0.006x
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd SHG:600671	-0.206x
Memsensing Microsystems Suzhou China Co Ltd SHG:688286	0.095x
Fidere Patrimonio SOCIMI SA MC:YFID	0.320x
China Sanjiang Fine Chemicals Company Limited F:8C9	0.032x
Servcorp Ltd AU:SRV	0.361x
Weave Communications Inc NYSE:WEAV	0.121x
Moura Dubeux Engenharia S.A SA:MDNE3	-0.029x

Annual Cash Flow Conversion Efficiency for Tellgen Corp (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tellgen Corp from 2012 to 2025. View Tellgen Corp (300642) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.48 Billion ≈ $216.63 Million	CN¥143.23 Million ≈ $20.96 Million	0.097x	-10.78%
2024-12-31	CN¥1.52 Billion ≈ $222.14 Million	CN¥164.62 Million ≈ $24.09 Million	0.108x	+31.75%
2023-12-31	CN¥1.54 Billion ≈ $224.72 Million	CN¥126.40 Million ≈ $18.50 Million	0.082x	-26.01%
2022-12-31	CN¥1.48 Billion ≈ $216.67 Million	CN¥164.72 Million ≈ $24.10 Million	0.111x	+88.02%
2021-12-31	CN¥1.40 Billion ≈ $204.32 Million	CN¥82.61 Million ≈ $12.09 Million	0.059x	-22.61%
2020-12-31	CN¥1.27 Billion ≈ $185.34 Million	CN¥96.83 Million ≈ $14.17 Million	0.076x	-48.90%
2019-12-31	CN¥1.17 Billion ≈ $171.01 Million	CN¥174.84 Million ≈ $25.59 Million	0.150x	-5.02%
2018-12-31	CN¥1.02 Billion ≈ $149.87 Million	CN¥161.32 Million ≈ $23.61 Million	0.158x	+33.13%
2017-12-31	CN¥895.86 Million ≈ $131.09 Million	CN¥106.00 Million ≈ $15.51 Million	0.118x	-65.30%
2016-12-31	CN¥288.65 Million ≈ $42.24 Million	CN¥98.42 Million ≈ $14.40 Million	0.341x	+1.41%
2015-12-31	CN¥192.33 Million ≈ $28.14 Million	CN¥64.67 Million ≈ $9.46 Million	0.336x	+7.97%
2014-12-31	CN¥131.05 Million ≈ $19.18 Million	CN¥40.81 Million ≈ $5.97 Million	0.311x	+12.41%
2013-12-31	CN¥95.04 Million ≈ $13.91 Million	CN¥26.33 Million ≈ $3.85 Million	0.277x	+193.02%
2012-12-31	CN¥72.47 Million ≈ $10.60 Million	CN¥6.85 Million ≈ $1.00 Million	0.095x	--

About Tellgen Corp

SHE:300642 China Medical Devices

Market Cap

$402.72 Million

CN¥2.75 Billion CNY

Market Cap Rank

#13483 Global

#4033 in China

Share Price

CN¥16.96

Change (1 day)

+1.62%

52-Week Range

CN¥11.22 - CN¥28.18

All Time High

CN¥46.24